7. Can Recombinant Zoster Vaccine Administration Decrease the Use of Herpes Zoster-related Pain Medication Across Randomized Controlled Studies?

BACKGROUND: Older and immunocompromised adults are at increased risk for herpes zoster (HZ) and often experience persistent, severe HZ-related pain, impacting their quality of life and activities of daily living. High vaccine efficacy (VE) of the adjuvanted recombinant zoster vaccine (RZV) in preven...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joon Hyung, Johnson, Robert, Kovac, Martina, Cunningham, Anthony L, Emmadi, Srikanth, Sullivan, Keith, Dagnew, Alemnew F, Curran, Desmond, Schuind, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776046/
http://dx.doi.org/10.1093/ofid/ofaa417.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776046/
http://dx.doi.org/10.1093/ofid/ofaa417.006

Ejemplares similares